220Indexed trials
Market Rank #9 · Evidence Tier A
Australia
Neuroscience Intelligence
Australia neuroscience intelligence: 220 indexed trials, 236 institutions, research score 45.65.
69Recruiting
236Research institutions
45.6Research score
Evidence profile
121Sponsors
23Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 45.6 · Data confidence 100.00 · Evidence 45.6
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
alzheimers53trials
parkinsons40trials
epilepsy33trials
stroke13trials
autism13trials
neuromuscular10trials
other_neurology10trials
depression9trials
multiple_sclerosis9trials
schizophrenia5trials
Leading indexed sponsors
Merck Sharp & Dohme LLC25trials
Hoffmann-La Roche14trials
Pfizer6trials
Biogen6trials
Eli Lilly and Company6trials
Novartis Pharmaceuticals6trials
AbbVie5trials
Fenix Innovation Group4trials
Eisai Inc.4trials
The University of Queensland4trials